S-Phase Response Protein (SPHAR)
SPHAR is able to correct the permanent repression of semiconservative DNA synthesis rates characteristic of these cells, was isolated. Wild-type SPHAR mRNA is expressed in all fibroblasts so far analyzed, including those of Fanconi anemia patients. Rabbit antiserum directed against a SPHAR peptide detects a protein of 7.9 kDa in Western blots of whole-cell extracts from proliferating, but not resting, fibroblasts. The deduced amino acid sequence of SPHAR contains a motif found in the cyclins, and it is proposed that SPHAR acts within the injected cell by interfering with the cyclin-controlled maintenance of S phase. In agreement with this proposal, normal cells transfected with an antisense SPHAR expression vector have a significantly reduced rate of DNA synthesis during S phase and a prolonged G2 phase, reflecting the need for postreplicative DNA processing before entry into mitosis.

Organism species: Homo sapiens (Human)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant S-Phase Response Protein (SPHAR) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to S-Phase Response Protein (SPHAR) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to S-Phase Response Protein (SPHAR) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for S-Phase Response Protein (SPHAR) CLIA Kit Customized Service Offer
n/a ELISA Kit for S-Phase Response Protein (SPHAR) ELISA Kit Customized Service Offer
  1. "Irreversible repression of DNA synthesis in Fanconi anemia cells is alleviated by the product of a novel cyclin-related gene."Mol. Cell. Biol. 15:305-314(1995) [PubMed] [Europe PMC] [Abstract]
  2. "The DNA sequence and biological annotation of human chromosome 1." Nature 441:315-321(2006) [PubMed] [Europe PMC] [Abstract]
  3. "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]